Dixon Technologies posted strong Q2 FY26 growth, with profit, EBITDA soaring and mixed division performance.
Alembic Pharma Gets USFDA Approval
Godrej Buys Land in North Bengaluru
SEBI to Standardize Index Derivative Expiries
GIC Re FY2025: Mixed Results & Growth
Exicom Announces Rights Issue & Debt-to-Equity Move
Mahindra Lifespace to Redevelop Mulund Housing Society
LTIMindtree Q1 Profit Rises 10%
News that matters the most ⚡